FDA
-
-
-
-
-
-
-
Tenax Therapeutics maintains LEVEL study enrollment target after review
-
-
-
-
-
-
-
This stock offers 'tremendous optionality in 2H25': analyst
-
-
-
-
-
-
-
Tenax Therapeutics Announces Professor Javed Butler, M.D., M.P.H, M.B.A., joins PH-HFpEF Scientific Advisory Board
-
-
-
-
-
-
-
Tenax Therapeutics Provides 2023 Business Update
-
-
-
-
-
-
-
Tenax Therapeutics (TENX) Announces Evaluation of Strategic Alternatives
-
-
-
-
-
-
-
Tenax Therapeutics Announces Two Presentations at Upcoming American College of Cardiology Scientific Sessions
-
-
-
-
-
-
-
Tenax Therapeutics Reports Third Quarter 2021 Results and Provides Business Update
-
330,192 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

